| scholarly article | Q13442814 |
| P2093 | author name string | Lu Zhang | |
| Yuhua Wang | |||
| Leaf Huang | |||
| Lei Miao | |||
| William Y Kim | |||
| Yang Xiong | |||
| C Michael Lin | |||
| Naihan Chen | |||
| P2860 | cites work | WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway | Q24324021 |
| DNA damage-mediated induction of a chemoresistant niche | Q24616267 | ||
| Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy | Q27690653 | ||
| Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells | Q27860717 | ||
| Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature | Q28509331 | ||
| Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy | Q29547379 | ||
| Wnt signalling in stem cells and cancer | Q29547862 | ||
| Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion | Q29617359 | ||
| In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro | Q29617927 | ||
| Wnt activity defines colon cancer stem cells and is regulated by the microenvironment | Q29618024 | ||
| Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy. | Q30572043 | ||
| Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model | Q33564844 | ||
| Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy | Q33572016 | ||
| Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging | Q33946993 | ||
| Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer | Q34063800 | ||
| Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. | Q34292287 | ||
| Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer | Q34479313 | ||
| Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors | Q34582878 | ||
| Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer | Q35230326 | ||
| Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity | Q35493953 | ||
| Three differentiation states risk-stratify bladder cancer into distinct subtypes | Q35750975 | ||
| Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment. | Q35865088 | ||
| Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy. | Q35945233 | ||
| Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner | Q36016318 | ||
| Wnt/beta-catenin signaling in cancer stemness and malignant behavior | Q36738603 | ||
| The tumor microenvironment is a dominant force in multidrug resistance. | Q36856829 | ||
| Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis | Q37254863 | ||
| Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. | Q37345878 | ||
| Fibronectin forms the most extensible biological fibers displaying switchable force-exposed cryptic binding sites | Q37385792 | ||
| Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice | Q37426354 | ||
| Lipid-coated Cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy | Q37531501 | ||
| Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy | Q37625480 | ||
| Molecular mechanisms behind the resistance of cisplatin in germ cell tumours | Q37666255 | ||
| Diminished WNT -> β-catenin -> c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors | Q37666383 | ||
| Dynamic interplay between the collagen scaffold and tumor evolution | Q37786073 | ||
| Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways | Q37820099 | ||
| Molecular mechanisms of cisplatin resistance in bladder cancer. | Q37982453 | ||
| Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer | Q37988897 | ||
| Docetaxel conjugate nanoparticles that target α-smooth muscle actin-expressing stromal cells suppress breast cancer metastasis. | Q38453301 | ||
| Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: molecular mechanisms unveiled by gene expression profiling | Q39197084 | ||
| The Role of STAT1 for Crosstalk between Fibroblasts and Colon Cancer Cells | Q39308458 | ||
| Leukemia cell to endothelial cell communication via exosomal miRNAs. | Q39314508 | ||
| Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway. | Q39524651 | ||
| MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. | Q39582762 | ||
| Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model | Q39661765 | ||
| Cisplatin: synthesis, antitumour activity and mechanism of action | Q39835716 | ||
| Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor-beta receptor inhibitor on extravasation of nanoparticles from neovasculature. | Q39911600 | ||
| Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. | Q40014237 | ||
| An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth. | Q40181708 | ||
| Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells | Q45069995 | ||
| Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link betw | Q46359179 | ||
| Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size | Q47348224 | ||
| Patterns of Wnt/Fzd/LRP gene expression during embryonic hematopoiesis. | Q50776483 | ||
| The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. | Q51285272 | ||
| Dickkopf-1 (DKK1) reveals that fibronectin is a major target of Wnt signaling in branching morphogenesis of the mouse embryonic lung. | Q52061734 | ||
| [The reversing and molecular mechanisms of miR-503 on the drug-resistance to cisplatin in A549/DDP cells]. | Q55464589 | ||
| Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes | Q56386325 | ||
| A mechanism of cisplatin action: antineoplastic effect through inhibition of neovascularization | Q74265444 | ||
| In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract | Q83181157 | ||
| Genetic heterogeneity and cancer drug resistance | Q83791245 | ||
| Aberrant expression of Wnt family contributes to the pathogenesis of diabetes-induced erectile dysfunction | Q86827577 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 27-41 | |
| P577 | publication date | 2015-08-15 | |
| P1433 | published in | Journal of Controlled Release | Q6295046 |
| P1476 | title | Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin | |
| P478 | volume | 217 |
| Q64264885 | Camouflaging Nanoparticles for Ratiometric Delivery of Therapeutic Combinations |
| Q33915162 | Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer |
| Q60923345 | Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy |
| Q37541971 | Enhancing Nanoparticle Accumulation and Retention in Desmoplastic Tumors via Vascular Disruption for Internal Radiation Therapy |
| Q42657219 | GDC-0449 improves the antitumor activity of nano-doxorubicin in pancreatic cancer in a fibroblast-enriched microenvironment |
| Q38796320 | Modifying the tumor microenvironment using nanoparticle therapeutics |
| Q64098474 | Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy |
| Q39380111 | Nanoformulations for combination or cascade anticancer therapy. |
| Q46940314 | Nanoscale Coordination Polymers Codeliver Chemotherapeutics and siRNAs to Eradicate Tumors of Cisplatin-Resistant Ovarian Cancer |
| Q38836010 | Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy |
| Q38747732 | Peptide-Based and Polypeptide-Based Gene Delivery Systems |
| Q38834366 | Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles. |
| Q64251593 | Strontium Sulfite: A New pH-Responsive Inorganic Nanocarrier to Deliver Therapeutic siRNAs to Cancer Cells |
| Q52579251 | Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment. |
| Q39019352 | Targeting Nanocarriers with Anisamide: Fact or Artifact? |
| Q38730195 | Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors |
| Q50579985 | The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors |
| Q47793665 | Transient and Local Expression of Chemokine and Immune Checkpoint Traps To Treat Pancreatic Cancer. |
| Q48244235 | Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy |
Search more.